{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-056027","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.191987+00:00","generated_at":"2026-06-15T23:00:23.602254+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"PowerUp Acquisition trust balance stands at $303.3M ($10.55/share) as of May 3, 2023","bullets":["Trust account held at Citibank with American Stock Transfer as trustee; balance $303,324,683.","Per-share trust value of $10.55 for public shares, updated ahead of extension vote.","Company filed Definitive Proxy Statement on April 21, 2023 for Extension Amendment Proposal.","Proceeds from IPO remain in trust pending potential business combination or extension."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-056027","json":"https://secwatch.observer/filing/0001104659-23-056027.json","markdown":"https://secwatch.observer/filing/0001104659-23-056027.md","text":"https://secwatch.observer/filing/0001104659-23-056027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/0001104659-23-056027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/tm2314762d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:00:23.602254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}